MedClub(@MedClubPage) 's Twitter Profile Photo


Signos y síntomas comunes de la amiloidosis de cadena ligera de inmunoglobulina.

J Natl Compr Canc Netw. 2023;21(1):83-90. doi:10.6004/jnccn.2022.7077

#Hematología #MedicinaInterna
Signos y síntomas comunes de la amiloidosis de cadena ligera de inmunoglobulina. 

J Natl Compr Canc Netw. 2023;21(1):83-90. doi:10.6004/jnccn.2022.7077
account_circle
Susanna Park(@zannaspark) 's Twitter Profile Photo

Hot off the press 📇 Thank you to Journal of the @NCCN for sending the print copy of Tiffany Li ‘s excellent paper on clinically important change in CIPN! Well done Tiffany Li - I am very proud! 🌟🌟🌟jnccn.org/view/journals/…

Hot off the press 📇 Thank you to @JNCCN for sending the print copy of  @Tiff_Li_ ‘s excellent paper on clinically important change in CIPN! Well done @Tiff_Li_ - I am very proud! 🌟🌟🌟jnccn.org/view/journals/…
account_circle
Yakup Ergün(@dr_yakupergun) 's Twitter Profile Photo

A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States

🔎1,937 pts who received at least 2-lines of therapy

OS➡️6.3 vs 6.6 mo (HR:0.99)

Conc: Regorafenib 🟰 TAS-102

Journal of the @NCCN
jnccn.org/view/journals/…

A Real-World Comparison of Regorafenib  and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States 

🔎1,937 pts who received at least 2-lines of therapy

OS➡️6.3 vs 6.6 mo (HR:0.99)

Conc: Regorafenib 🟰 TAS-102  

@JNCCN 
jnccn.org/view/journals/…
account_circle
Amar Gajjar(@DrAmarGajjar) 's Twitter Profile Photo

A new review, published by Journal of the @NCCN, reveals how incorporating molecular risk into treatment stratification may improve outcomes for infants & young children with medulloblastoma. tinyurl.com/ef3acsrd Dr.Aditi Bagchi MD PhD Giles Robinson Sandeep Dhanda, Ph.D.

A new review, published by @JNCCN, reveals how incorporating molecular risk into treatment stratification may improve outcomes for infants & young children with medulloblastoma. tinyurl.com/ef3acsrd @DrAditiBagchi @DrGilesRobinson @drsandeepdhanda #SJiMB21
account_circle
OncLive.com(@OncLive) 's Twitter Profile Photo

An early detection and prevention program for pancreatic cancer proved to be feasible on an international scale, according to findings from the observational PRECEDE study. Journal of the @NCCN onclive.com/view/internati…

An early detection and prevention program for pancreatic cancer proved to be feasible on an international scale, according to findings from the observational PRECEDE study. @JNCCN #pancsm #oncology onclive.com/view/internati…
account_circle
Mostafa R Mohamed(@m_refaat84) 's Twitter Profile Photo

Our new article @jnccn: we externally validated a group of clinical, lab & GA risk factors for unplanned hospitalization in older adults with advanced cancer receiving chemo, identified in prior study by CARG Heidi Klepin Supriya Mohile Melissa (Kah Poh) Loh, MBBCh BAO, MS, FACCC Cancer and Aging Research Group (CARG) #GeriOnc
jnccn.org/view/journals/…

Our new article @jnccn: we externally validated a group of clinical, lab & GA risk factors for unplanned hospitalization in older adults with advanced cancer receiving chemo, identified in prior study by CARG @HKlepinMD @rochgerionc @MelissaLoh21 @myCARG 
jnccn.org/view/journals/…
account_circle
Stanley Ozogbo MD, MPH(@SOzogbo) 's Twitter Profile Photo

Day 2 National Comprehensive Cancer Network (NCCN) conference:

A second abstract poster with a expert tour guide presentation led by Dr Wui-Jin Koh, the CMO National Comprehensive Cancer Network (NCCN). A remarkable experience for me delivering while placed on the spot.

Challenge, opportunities and networking

Journal of the @NCCN
H.O.M.E Mentorship Program
IMG Oncologists

Day 2 @NCCN conference:

A second abstract poster with a expert tour guide presentation led by Dr Wui-Jin Koh, the CMO @NCCN. A remarkable experience for me delivering while placed on the spot.

Challenge, opportunities and networking 

@JNCCN 
@hemeoncfellow 
@IMG_Oncologists
account_circle
Luca Arecco, MD(@Lucarecco) 's Twitter Profile Photo

Just released on Journal of the @NCCN this effort led by Matteo Lambertini, MD PhD aiming to assess the gonadotoxicity of Anti-HER2 agents (alone or with Paclitaxel) on young pts with HER2+ BC through an analysis of patients included in the trial.
 
⬇️ Details in the following thread!

Just released on @JNCCN this effort led by @matteolambe aiming to assess the gonadotoxicity of Anti-HER2 agents (alone or with Paclitaxel) on young pts with HER2+ BC through an analysis of patients included in the #NeoALLTO trial. 
 
⬇️ Details in the following thread!
account_circle
Giles Robinson(@DrGilesRobinson) 's Twitter Profile Photo

“This review & the trial highlight the importance of ongoing preclinical research to identify novel therapies for pediatric medulloblastoma patients.” Read Dr. Nick Gottardo’s commentary on my & Dr.Aditi Bagchi MD PhD’s recent contribution to Journal of the @NCCN tinyurl.com/47hunesk

“This review & the #SJiMB21 trial highlight the importance of ongoing preclinical research to identify novel therapies for pediatric medulloblastoma patients.” Read Dr. Nick Gottardo’s commentary on my & @DrAditiBagchi’s recent contribution to @JNCCN tinyurl.com/47hunesk
account_circle
Amar Gajjar(@DrAmarGajjar) 's Twitter Profile Photo

Dr. Nick Gottardo, of Telethon Kids Institute, provides a commentary on Dr.Aditi Bagchi MD PhD & Giles Robinson’s Journal of the @NCCN review, which describes how we’ve come full circle in our use of chemotherapy to delay CSI for infants with G3/G4 . tinyurl.com/47hunesk

Dr. Nick Gottardo, of @telethonkids, provides a commentary on @DrAditiBagchi & @DrGilesRobinson’s @JNCCN review, which describes how we’ve come full circle in our use of chemotherapy to delay CSI for infants with G3/G4 #medulloblastoma. tinyurl.com/47hunesk #SJiMB21
account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

🔥HER2 Targeting in Esophagogastric Cancer: Redefining the Landscape & Breaking Barriers
doi.org/10.6004/jnccn.…
Journal of the @NCCN
👏great review
👉rapidly changing landscape
- from trastuzumab + IO to ADCs, vaccines & CARs
- from peri-OP to treatment beyond progression
ESMO - Eur. Oncology OncoAlert

🔥HER2 Targeting in Esophagogastric Cancer: Redefining the Landscape & Breaking Barriers
doi.org/10.6004/jnccn.…
@JNCCN 
👏great review
👉rapidly changing landscape 
- from trastuzumab + IO to ADCs, vaccines & CARs
- from peri-OP to treatment beyond progression
@myESMO @OncoAlert
account_circle
Arndt Vogel(@ArndtVogel) 's Twitter Profile Photo

🔥A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic in 🇺🇸
Journal of the @NCCN
doi.org/0.6004/jnccn.2…
🔎1,937 pts
👉no difference -> mOS 6.66 vs 6.30 mo
😇Will TAS-102 leapfrog in SUNLIGHT?
ESMO - Eur. Oncology OncoAlert

🔥A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic #ColorectalCancer in 🇺🇸
@JNCCN 
doi.org/0.6004/jnccn.2…
🔎1,937 pts 
👉no difference -> mOS 6.66 vs 6.30 mo
😇Will TAS-102 leapfrog in SUNLIGHT?
@myESMO @OncoAlert
account_circle
Avirup Guha, MBBS, MPH, FICOS, FACC, FAHA(@avirupguha) 's Twitter Profile Photo

New Journal of the @NCCN pub: Social Determinants of Health and Racial Disparities in Cardiac Events in . Flawless and work by Nickolas Stabellini.
1. Adverse (a) SDOH → ↑ 2-year MACE in patients with
2. Black women have ↑ adverse SDOH /1

New @JNCCN pub: Social Determinants of Health and Racial Disparities in Cardiac Events in #bcsm. Flawless #traditionalstats and #ML work by @nickolastab. 
1. Adverse (a) SDOH →  ↑ 2-year MACE in patients with #bcsm 
2. Black women have ↑ adverse SDOH #cardioonc /1
account_circle
ACSNews(@ACSNews) 's Twitter Profile Photo

New ACS Research led by American Cancer Society Jingxuan Zhao in Journal of the @NCCN shows people surviving who reported feeling more lonely experienced a higher mortality risk. Read more here: pressroom.cancer.org/releases?item=…

New @ACS_Research led by @AmericanCancer @jingxuan_zhao in @JNCCN shows people surviving #cancer who reported feeling more lonely experienced a higher mortality risk. Read more here: pressroom.cancer.org/releases?item=…
account_circle